Joshua H. Bilenker's Net Worth
$72.7 Million
Who is Joshua H. Bilenker?
Joshua H. Bilenker has an estimated net worth of $72.7 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Gossamer Bio, Inc., ViewRay, Inc., Loxo Oncology, Inc., T2 Biosystems, Inc., and Roka BioScience, Inc..
SEC CIK
Joshua H. Bilenker's CIK is 0001612312
Past Insider Trading and Trends
2018 was Joshua H. Bilenker's most active year for acquiring shares with 29 total transactions. Joshua H. Bilenker's most active month to acquire stocks was the month of May. 2018 was Joshua H. Bilenker's most active year for disposing of shares, totalling 157 transactions. Joshua H. Bilenker's most active month to dispose stocks was the month of October. 2021 saw Joshua H. Bilenker paying a total of $500,000.00 for 62,295 shares, this is the most they've acquired in one year. In 2019 Joshua H. Bilenker cashed out on 1,452,151 shares for a total of $341,255,485.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $5.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
∞
| 20K |
$25.00 | $500,000.00 | 20K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ViewRay, Inc. (VRAYQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 18.96K |
—
|
—
| 18.96K |
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Loxo Oncology, Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -192.71K |
$235.00 | -$45,286,145.00 |
0
|
Feb 15
| |||
Form 4/A
| +5.61% | 7.5K |
$1.18 | $8,880.00 | 141.21K |
Scheduled
|
Jul 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$74.57 | -$2,436,035.15 | 164.41K |
Scheduled
|
Dec 10 - Dec 11
| ||
Form 4
| +21.42% | 29K |
$75.90 | -$2,722,838.23 | 164.41K |
Scheduled
|
Nov 26 - Nov 27
| ||
Form 4
|
—
|
0
|
$84.30 | -$3,225,881.64 | 135.41K |
Scheduled
|
Oct 3 - Oct 4
| ||
Form 4
|
—
|
0
|
$83.85 | -$3,294,058.18 | 135.41K |
Scheduled
|
Sep 12 - Sep 13
| ||
Form 4
|
—
|
0
|
$80.30 | -$3,164,501.29 | 135.41K |
Scheduled
|
Aug 13 - Aug 14
| ||
Form 4
|
—
|
0
|
$92.33 | -$2,734,404.24 | 135.41K |
Scheduled
|
Jul 9 - Jul 10
| ||
Form 4
| -10.40% | -19.00K |
$89.82 | -$10,130,444.40 | 163.71K |
Scheduled
|
Jun 8 - Jun 20
| ||
Form 4
|
—
|
0
|
$68.85 | -$2,029,886.46 | 182.71K |
Scheduled
|
May 14 - May 15
| ||
Form 4
|
—
|
0
|
$66.15 | -$1,949,092.59 | 182.71K |
Scheduled
|
Apr 24 - Apr 25
| ||
Form 4
|
—
|
0
|
$66.36 | -$1,955,296.42 | 182.71K |
Scheduled
|
Mar 13 - Mar 14
| ||
Form 4
|
—
|
0
|
$48.88 | -$1,430,768.68 | 182.71K |
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
|
—
|
0
|
$44.70 | -$1,305,338.64 | 182.71K |
Scheduled
|
Jan 16 - Jan 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
$41.15 | -$1,199,098.59 | 182.71K |
Scheduled
|
Dec 14 - Dec 15
| ||
Form 4
| -3.18% | -6.00K |
$37.82 | -$1,098,988.63 | 182.71K |
Scheduled
|
Nov 20 - Nov 28
| ||
Form 4
|
—
|
0
|
$44.01 | -$1,284,909.56 | 188.71K |
Scheduled
|
Oct 30 - Oct 31
| ||
Form 4
|
—
|
0
|
$45.10 | -$1,317,515.89 | 188.71K |
Scheduled
|
Sep 18 - Sep 19
| ||
Form 4
|
—
|
0
|
$37.37 | -$1,085,688.34 | 188.71K |
Scheduled
|
Aug 14 - Aug 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
T2 Biosystems, Inc. (TTOO) Snapshot price: $2.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||